OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy
Nur Aininie Yusoh, Paul R. Tiley, Steffan D. James, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6922-6937
Open Access | Times Cited: 10

Showing 10 citing articles:

Exploring the Anti-Colon Cancer Potential of Polygonum minus: Integrating In Vitro and In Silico Studies
Zhongming Yang, Zhongguo Yang, Md Zuki Abu Bakar, et al.
Food Bioscience (2025) Vol. 64, pp. 105853-105853
Closed Access | Times Cited: 3

Bioactivity evaluation of Polygonum minus and identification of synergistic phytochemicals with 5-fluorouracil for colon cancer treatment
Zhongming Yang, Zhongguo Yang, Md Zuki Abu Bakar, et al.
Microchemical Journal (2025) Vol. 210, pp. 112917-112917
Closed Access | Times Cited: 2

Tracking the cellular uptake and phototoxicity of Ru(ii)-polypyridyl-1,8-naphthalimide Tröger's base conjugates
Sandra A. Bright, Marialuisa Erby, Fergus E. Poynton, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 4, pp. 344-359
Open Access | Times Cited: 3

Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling
Larissa M. Bomfim, Sara P. Neves, Amanda M. R. M. Coelho, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor
Yuliang Yang, Ya Gao, Yanyan Sun, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13731-13745
Closed Access | Times Cited: 6

PARP inhibition enhances exemestane efficacy in triple-negative breast cancer
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

CyreneTM as a green alternative to N,N’-dimethylformamide (DMF) in the synthesis of MLCT-emissive ruthenium(II) polypyridyl complexes for biological applications†
Steven W. James, Christopher E. Elgar, Dandan Chen, et al.
Dalton Transactions (2024) Vol. 53, Iss. 46, pp. 18506-18514
Open Access | Times Cited: 1

Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access

A Progressively Disassembled DNA Repair Inhibitors Nanosystem for the Treatment of BRCA Wild-Type Triple-Negative Breast Cancer
Weimin Fang, Jinghao Wang, Xiaocong Ma, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 6001-6019
Open Access | Times Cited: 1

Page 1

Scroll to top